122 related articles for article (PubMed ID: 3726072)
1. Plasma fluphenazine levels in patients receiving two doses of fluphenazine decanoate.
Marder SR; Hubbard JW; Van Putten T; Hawes EM; McKay G; Mintz J; May PR; Midha KK
Psychopharmacol Bull; 1986; 22(1):264-6. PubMed ID: 3726072
[No Abstract] [Full Text] [Related]
2. Plasma levels of neuroleptic in patients receiving depot fluphenazine.
Cohen BM; Waternaux C; Chouinard G; Sommer BR; Jones B
J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997
[TBL] [Abstract][Full Text] [Related]
3. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
Wiles DH; Gelder MG
Adv Biochem Psychopharmacol; 1980; 24():599-602. PubMed ID: 7405678
[No Abstract] [Full Text] [Related]
4. Plasma levels of parent drug and metabolites in patients receiving oral and depot fluphenazine.
Marder SR; Van Putten T; Aravagiri M; Hubbard JW; Hawes EM; McKay G; Midha KK
Psychopharmacol Bull; 1989; 25(3):479-82. PubMed ID: 2626520
[TBL] [Abstract][Full Text] [Related]
5. Plasma fluphenazine levels measured by high-performance liquid chromatography in patients treated with depot injections.
Jouen F; Verité P; André D; Colonna L; Boucly P
Arzneimittelforschung; 1993 May; 43(5):509-11. PubMed ID: 8328993
[TBL] [Abstract][Full Text] [Related]
6. Monitoring plasma levels of fluphenazine during chronic therapy with fluphenazine decanoate.
Miller RS; Peterson GM; McLean S; Westhead TT; Gillies P
J Clin Pharm Ther; 1995 Apr; 20(2):55-62. PubMed ID: 7650075
[TBL] [Abstract][Full Text] [Related]
7. Study of accumulation of fluphenazine enanthate and fluphenazine decanoate, long-acting neuroleptic drugs, after repeated administrations by means of their inhibitory effects on the discriminated avoidance response in rats.
Kuribara H; Tadokoro S
J Toxicol Sci; 1979 May; 4(2):87-98. PubMed ID: 501762
[No Abstract] [Full Text] [Related]
8. Plasma levels of fluphenazine decanoate. Effects of site of injection, massage and muscle activity.
Soni SD; Wiles D; Schiff AA; Bamrah JS
Br J Psychiatry; 1988 Sep; 153():382-4. PubMed ID: 3250675
[TBL] [Abstract][Full Text] [Related]
9. Is the treatment of tobacco dependence with fluphenazine decanoate a causal treatment?
Drtil J; Balasová G; Jandová E; Duchácková K
Act Nerv Super (Praha); 1990 Dec; 32(4):301-2. PubMed ID: 2082649
[No Abstract] [Full Text] [Related]
10. Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.
Curry SH; Whelpton R; de Schepper PJ; Vranckx S; Schiff AA
Br J Clin Pharmacol; 1979 Apr; 7(4):325-31. PubMed ID: 444352
[TBL] [Abstract][Full Text] [Related]
11. Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs.
Dreyfuss J; Shaw JM; Ross JJ
J Pharm Sci; 1976 Sep; 65(9):1310-5. PubMed ID: 966144
[TBL] [Abstract][Full Text] [Related]
12. Persistence of fluphenazine in plasma after decanoate withdrawal.
Gitlin MJ; Midha KK; Fogelson D; Nuechterlein K
J Clin Psychopharmacol; 1988 Feb; 8(1):53-6. PubMed ID: 3351000
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
Tsutsul'kovskaia MIa; Minsker EI; Panteleeva GP; Mazurskii MB; Pekunova LG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):753-8. PubMed ID: 4718619
[No Abstract] [Full Text] [Related]
14. Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
Viala A; Hou N; Ba B; Durand A; Dufour H; D'Agostino N; Berda C; Jørgensen A
Psychopharmacology (Berl); 1984; 83(2):147-50. PubMed ID: 6146995
[TBL] [Abstract][Full Text] [Related]
15. Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate.
Brown WA; Silver MA
J Clin Psychopharmacol; 1985 Jun; 5(3):143-7. PubMed ID: 3998204
[TBL] [Abstract][Full Text] [Related]
16. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
Zhang YF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):182-5. PubMed ID: 7333179
[No Abstract] [Full Text] [Related]
17. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
Roose K
Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
[TBL] [Abstract][Full Text] [Related]
18. Fluphenazine decanoate in the treatment of chorea: a double-blind study.
Terrence CF
Curr Ther Res Clin Exp; 1976 Aug; 20(2):177-83. PubMed ID: 133787
[No Abstract] [Full Text] [Related]
19. Depot fluphenazine enanthate and decanoate: comparative rates of release in dogs.
Dreyfuss J; Ross JJ; Shaw JM; Miller I; Schreiber EC
J Pharm Pharmacol; 1975 Oct; 27(10):791-2. PubMed ID: 241800
[No Abstract] [Full Text] [Related]
20. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
Wiles DH; Gelder MG
Br J Clin Pharmacol; 1979 Dec; 8(6):565-70. PubMed ID: 533577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
